Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gesine Bug

Showing results (101-110 of 165) with videos related to

Pageof 17
Sort By:
The Lancet. Haematology|April 10, 2018
Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trialMartin Wermke, Julia Eckoldt, Katharina S Götze, et al.
Bone Marrow Transplantation|June 13, 2020
Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow TransplantationEolia Brissot, Myriam Labopin, Frédéric Baron, et al.
Leukemia Research|December 24, 2010
Increased HDAC1 deposition at hematopoietic promoters in AML and its association with patient survivalLara Tickenbrock, Hans-Ulrich Klein, Cristina Trento, et al.
Bone Marrow Transplantation|August 20, 2024
Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMTArnon Nagler, Myriam Labopin, Urpu Salmenniemi, et al.
Bone Marrow Transplantation|November 9, 2021
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemiaChristoph Schmid, Myriam Labopin, Nicolaas Schaap, et al.
Annals of Hematology|June 5, 2026
What is the best path towards allogeneic transplantation in MDS and AML? A survey among German-spreaking centers for allogeneic hematopoietic stem cell transplantationStefan W Krause, Wolfgang Bethge, Gesine Bug, et al.
Bone Marrow Transplantation|May 2, 2022
Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemiaArnon Nagler, Christophe Peczynski, Bhagirathbhai Dholaria, et al.
Leukemia|March 7, 2019
Correction: LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AMLJessica Barth, Khalil Abou-El-Ardat, Denis Dalic, et al.
Cell Reports|May 16, 2019
Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous TransplantationChristina A Ortmann, Lena Dorsheimer, Khalil Abou-El-Ardat, et al.
Leukemia|January 26, 2019
LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AMLJessica Barth, Khalil Abou-El-Ardat, Denis Dalic, et al.
Pageof 17

Showing results (101-110 of 165) with videos related to

Sort By:
Pageof 17
The Lancet. Haematology|April 10, 2018
Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trialMartin Wermke, Julia Eckoldt, Katharina S Götze, et al.
Bone Marrow Transplantation|June 13, 2020
Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow TransplantationEolia Brissot, Myriam Labopin, Frédéric Baron, et al.
Leukemia Research|December 24, 2010
Increased HDAC1 deposition at hematopoietic promoters in AML and its association with patient survivalLara Tickenbrock, Hans-Ulrich Klein, Cristina Trento, et al.
Bone Marrow Transplantation|August 20, 2024
Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMTArnon Nagler, Myriam Labopin, Urpu Salmenniemi, et al.
Bone Marrow Transplantation|November 9, 2021
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemiaChristoph Schmid, Myriam Labopin, Nicolaas Schaap, et al.
Annals of Hematology|June 5, 2026
What is the best path towards allogeneic transplantation in MDS and AML? A survey among German-spreaking centers for allogeneic hematopoietic stem cell transplantationStefan W Krause, Wolfgang Bethge, Gesine Bug, et al.
Bone Marrow Transplantation|May 2, 2022
Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemiaArnon Nagler, Christophe Peczynski, Bhagirathbhai Dholaria, et al.
Leukemia|March 7, 2019
Correction: LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AMLJessica Barth, Khalil Abou-El-Ardat, Denis Dalic, et al.
Cell Reports|May 16, 2019
Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous TransplantationChristina A Ortmann, Lena Dorsheimer, Khalil Abou-El-Ardat, et al.
Leukemia|January 26, 2019
LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AMLJessica Barth, Khalil Abou-El-Ardat, Denis Dalic, et al.
Pageof 17